Bibliography
- TRACY JW, WEBSTER LT, JR.: Chemotherapy of parasitic infections. In: Goodman and Gilman 's. The pharmacol-ogical basis of therapeutics (9th Ed.). Hardman JG, Molinoff PB, Ruddon RW, Goodman A (Eds.), McGraw-Hill Companies, Inc., New York, USA (1996):955.
- CAVALIER-SMITH T: Kingdom Protozoa and its 18 phyla. Microbiol. Rev. (1993) 57:953–994.
- CAVALIER-SMITH T: Principles of protein and lipid targeting in secondary symbiogenesis: euglenoid, dinoflagellated and sporozoan origins and the eukaryote family tree. J Eukaryot. Microbiol (1999) 46:347–366.
- World Health Organization report on infectiousdiseases, removing obstacles to healthy development. WHO, Geneva (1999).
- CASTEEL DA.: Antimalarial agents. In: Burgerfs medicinal chemistry and drug discovery (5th Ed.). Wolff M (Ed.). John Wiley & Sons, Inc. New York, USA (1997):4.
- PATARROYO ME: Different strategies towards the design of a synthetic subunit malaria vaccine. Collect. Symp. Ser. (1999) 1 : 108-1 2 1.
- PATARROYO ME. Synthetic malaria vaccines. Nat urwiss. Rundsch. (1996) 49:90–96.
- STONTE JA, SLAOUI M, HEPPNER DG et al: A pr eliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. New England J. Med. (1997) 336:86–91.
- STOUTE JA, KESTER KE, KRZYCH U et al.: Long-term efficacy and immune responses following immuniza-tion with the RTS,S malaria vaccine. J Infect. Dis. (1998) 178:1139–1144.
- LALVANI A, MORIS P, VOSS G et al: Potent induction offocused Th1 -type cellular and humor al immune responses by RTS,S/SBAS2, a recombinant Plasmo-dium fakiparum malaria vaccine. J. Infect. Dis. (1999) 180:1656–1664.
- DOOLAN DL, HOFFMAN SL: Multi-gen vaccination against malaria: a multistage, multi-immune response approach. Parasitol. Today (1997) 13:171–178.
- ANDERS RF, SAUL A: Malaria vaccines. Parasitol. Today (2000) 16:444–447.
- DAUBERSIES P, THOMAS AW, MILLET P et al: Protection against Plasmodium falciparum malaria in chimpan-zees by immunization with the conserved pre-erythrocytic liver-stage antigen. Nature Med. (2000) 6:1258–1263.
- TELFOR SR, SPIELMAN A: Babesiosis of humans. In: Topley & Wilson's Microbiology and Microbial Infection Volume 5 (9th Ed.). Cox FEG et al. (Eds.), Arnold, London (1999)349–359.
- CARRERO RA, MARTIN DS, BARTA JR: Cryptosporidium is more closely related to the gregarines than to coccidian as shown by phylogenetic analysis of apicomplex an parasites inferred using a small subunit ribosomal RNA gene sequences. Parasit. Res. (2000) 85:899–904.
- BERMAN J: Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. (1997) 24:684–703.
- NORRIS K, SCHRIMPF JE, SZABO MJ: Identification of the gene family encoding the 160 -KDa Trypanosoma cruzi complement regulatory protein. Infect. Immun. (1997) 65:349–357.